Ruegsegger Frederick J 4
4 · Transcept Pharmaceuticals Inc · Filed Jan 25, 2012
Insider Transaction Report
Form 4
Ruegsegger Frederick J
Director
Transactions
- Award
Common Stock (right to buy)
2012-01-24+7,000→ 7,000 totalExercise: $8.18Exp: 2022-01-24→ Common Stock (7,000 underlying)
Footnotes (1)
- [F1]The option vests in twelve equal monthly installments beginning on February 24, 2012.